Cti Biopharma
Get Full AccessDescription
- CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It develops pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase III clinical trials for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Vernalis (R&D) Limited. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was founded in 1991 and is headquartered in Seattle, Washington.
-
Headquarters:3101 Western Avenue #600, Seattle, Washington, United States
More -
Phone Number: +1 206-282-7100
-
Website: https://www.ctibiopharma.com
-
Employees:124
-
Revenue:$100 - 250M
-
Legal Name:Cti Biopharma
-
Cti Biopharma's Social Media
-
Is this data correct?
-
| NAICS Code: 541715 |
NYSE: CTIC
Show More
Frequently Asked Questions regarding Cti Biopharma
-
Where are Cti Biopharma's Headquarters?
Cti Biopharma's Headquarters are in 3101 Western Avenue #600,Seattle,Washington,United States
-
What is Cti Biopharma's phone number?
Cti Biopharma's phone number is +1 206-282-7100
-
What is Cti Biopharma's stock symbol?
Cti Biopharma's stock symbol is CTIC
-
What is Cti Biopharma's official website?
Cti Biopharma's official website is https://www.ctibiopharma.com
-
What is Cti Biopharma's Revenue?
Cti Biopharma's revenue is $100 - 250M
-
What is Cti Biopharma's NAICS code?
Cti Biopharma's NAICS code is 541715
-
How many employees are working in Cti Biopharma
Cti Biopharma has 124 employees
-
What is Cti Biopharma's Industry?
Cti Biopharma is in the industry of Biotechnology

